Publication

Safety and Tolerability of Bifidobacterium Longum Subspecies Infantis LMG11588 Supplementation in Healthy Term Infants

Growth & Development
1 min read

Bifidobacterium longum subsp. infantis (B. infantis) is a unique probiotic as it is able to metabolize the full range of human milk oligosaccharide in breastfed infants. A recent trial evaluated healthy breastfed and formula-fed infants randomized to receive a placebo-control or a low or high dose B. infantis supplement for 8 weeks. Both the low and high dose of the B. infantis LMG11588 supplements were shown to support normal infant growth, be safe and well-tolerated.

Author(s): M.R.Z. Capeding, L.C. M. Phee, Chang Ming, Colin I. Cercamondi

Download publication
person-default
M.R.Z. Capeding
person-default
L.C. M. Phee
person-default
Chang Ming
person-default
Colin I. Cercamondi

If you liked this post you may also like

Please log in to your profile so we can show recommended content.